Operating Lease, Right-of-Use Asset of ABVC BIOPHARMA, INC. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ABVC BIOPHARMA, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • ABVC BIOPHARMA, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $369,135, a 27% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ABVC BIOPHARMA, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $369,135 -$138,524 -27% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $459,325 -$147,676 -24% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $533,460 -$174,563 -25% 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 $640,387 -$168,896 -21% 31 Dec 2024 10-Q 03 Nov 2025 2025 Q3
Q3 2024 $507,659 -$392,158 -44% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $607,001 -$392,644 -39% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $708,023 -$390,737 -36% 31 Mar 2024 10-Q 17 May 2024 2024 Q1
Q4 2023 $809,283 -$351,858 -30% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 $899,817 -$344,113 -28% 30 Sep 2023 10-Q 15 Nov 2023 2023 Q3
Q2 2023 $999,645 -$294,905 -23% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $1,098,760 -$283,935 -21% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $1,161,141 -$310,758 -21% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 $1,243,930 -$310,350 -20% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $1,294,550 -$341,886 -21% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $1,382,695 -$332,045 -19% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $1,471,899 -$300,848 -17% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $1,554,280 -$288,708 -16% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $1,636,436 +$1,253,342 +327% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $1,714,740 +$1,265,057 +281% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $1,772,747 +$1,248,302 +238% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $1,842,988 +$1,485,056 +415% 30 Sep 2020 10-Q 17 Nov 2020 2020 Q3
Q2 2020 $383,094 -$48,295 -11% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $449,683 -$55,622 -11% 31 Mar 2020 10-Q 29 Jun 2020 2020 Q1
Q4 2019 $524,445 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q3 2019 $357,932 30 Sep 2019 10-Q 18 Nov 2019 2019 Q3
Q2 2019 $431,389 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $505,305 31 Mar 2019 10-Q 28 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.